We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+28.17%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$3.55B
AUM Growth
+$522M
Cap. Flow
-$54.7M
Cap. Flow %
-1.54%
Top 10 Hldgs %
31.77%
Holding
144
New
18
Increased
29
Reduced
10
Closed
28

Top Buys

Rank Stock Value
1
BEP icon
Brookfield Renewable
BEP
+$36.7M
2
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$29.3M
3
TREX icon
Trex
TREX
+$26.3M
4
NOVT icon
Novanta
NOVT
+$24.2M
5
DT icon
Dynatrace
DT
+$18.1M

Top Sells

Rank Stock Value
1
TMX
Terminix Global Holdings, Inc.
TMX
+$41.9M
2
PEGI
Pattern Energy Group Inc. Class A
PEGI
+$28.9M
3
ANET icon
Arista Networks
ANET
+$28M
4
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$22.6M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$22.5M

Sector Composition

Rank Sector Weight
1 Healthcare 46.72%
2 Technology 21.45%
3 Industrials 9.37%
4 Consumer Discretionary 6.67%
5 Utilities 3.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASND icon
1
Ascendis Pharma A/S
ASND
$16.5B
$236M 6.66%
1,698,648
– –
ZGNX
2
DELISTED
Zogenix, Inc.
ZGNX
$148M 4.17%
2,841,300
– –
SRPT icon
3
Sarepta Therapeutics
SRPT
$1.64B
$129M 3.62%
996,000
-223,000
-18% -$22.5M
TTD icon
4
Trade Desk
TTD
$8.59B
$110M 3.11%
4,250,000
– –
AIMT
5
DELISTED
Aimmune Therapeutics
AIMT
$103M 2.91%
3,084,000
– –
BHVN
6
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$89M 2.51%
1,634,000
– –
FIVN icon
7
FIVE9
FIVN
$2.12B
$82M 2.31%
1,250,000
– –
TWLO icon
8
Twilio
TWLO
$29B
$81.3M 2.29%
827,000
– –
ROP icon
9
Roper Technologies
ROP
$38.5B
$75.8M 2.14%
214,000
– –
WCN
10
Waste Connections
WCN
$41.9B
$73M 2.06%
804,000
– –
LOW icon
11
Lowe's Companies
LOW
$118B
$70.7M 1.99%
590,400
+8,600
+1% +$983K
PANW icon
12
Palo Alto Networks
PANW
$265B
$66.4M 1.87%
1,722,000
– –
SPLK
13
DELISTED
Splunk Inc
SPLK
$64.1M 1.81%
428,000
– –
MYOV
14
DELISTED
Myovant Sciences Ltd.
MYOV
$64M 1.8%
4,126,131
-568,786
-12% -$5.73M
XYL icon
15
Xylem
XYL
$27.3B
$62.2M 1.75%
789,800
+2,700
+0.3% +$210K
LRCX icon
16
Lam Research
LRCX
$372B
$58.8M 1.66%
2,010,000
-260,000
-11% -$6.9M
MTD icon
17
Mettler-Toledo International
MTD
$27.9B
$57.6M 1.62%
72,610
– –
SAGE
18
DELISTED
Sage Therapeutics
SAGE
$57M 1.61%
790,000
– –
XIFR
19
XPLR Infrastructure LP
XIFR
$1.12B
$56.1M 1.58%
1,065,922
+2,000
+0.2% +$104K
HUBS icon
20
HubSpot
HUBS
$11.9B
$55.5M 1.56%
350,000
– –
ASML icon
21
ASML
ASML
$634B
$53.5M 1.51%
180,900
+2,500
+1% +$675K
W icon
22
Wayfair
W
$11.9B
$51.8M 1.46%
573,000
– –
DNTH icon
23
Dianthus Therapeutics
DNTH
$6.16B
$51.5M 1.45%
212,118
+27,403
+15% +$5.12M
COLL icon
24
Collegium Pharmaceutical
COLL
$1.17B
$50M 1.41%
2,427,976
– –
LII icon
25
Lennox International
LII
$14.5B
$48.8M 1.37%
200,000
– –
1
2 3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Eventide Asset Management held 144 positions worth $3.55B, up 17% from $3.03B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Eventide Asset Management's Q4 2019 filing shows 18 new, 29 increased, 10 reduced and 28 closed positions. Its largest new stake was Trex: 598,000 shares worth $26.9M. The largest sale was Terminix Global Holdings, Inc., an estimated $41.9M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 42% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q4 2019 buy was Trex: 598,000 shares worth $26.9M.
  • Eventide Asset Management added most to Brookfield Renewable in Q4 2019, an estimated $36.7M increase.
  • Eventide Asset Management's biggest Q4 2019 reduction was Lakefront Biotherapeutics American Depositary Shares, cutting an estimated $22.6M.
  • Eventide Asset Management fully exited Terminix Global Holdings, Inc. in Q4 2019, selling an estimated $41.9M.
  • Eventide Asset Management's ten largest holdings make up 32% of its $3.55B portfolio in Q4 2019.
  • Eventide Asset Management opened 18 new positions and closed 28 in Q4 2019.
  • Eventide Asset Management's portfolio value rose 17% quarter-over-quarter to $3.55B.

Based on Eventide Asset Management's 13F filing for Q4 2019, filed 29 Jan 2020.